期刊文献+

突变K-ras基因修饰的肺癌树突状细胞疫苗的体内实验研究 被引量:3

下载PDF
导出
出处 《中国肺癌杂志》 CAS 2001年第6期475-476,共2页 Chinese Journal of Lung Cancer
基金 国家自然科学基金 ( 30 0 0 0 2 0 6 )资助
  • 相关文献

参考文献4

  • 1Banchereau J,Steinman RM.Dendritic cells and the control of immunity[].Nature.1998
  • 2Inaba K,Inaba M,Romani N,et al.Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with GM-CSF[].The Journal of Experimental Medicine.1992
  • 3Abrams SI,Hand PH,Tsang KY,et al.Mutant ras epitopes as targets for cancer vaccines[].Seminars in Oncology.1996
  • 4Rosenberg SA.A new era for cancer immunotherapy based on the genes that encode cancer antigens[].Immunity.1999

同被引文献64

  • 1周清华,孙芝琳,覃扬,赵建升,伍伫.肺癌病人Ki-ras基因点突变与术后长期生存关系的研究[J].中国胸心血管外科临床杂志,1994,1(2):66-67. 被引量:6
  • 2[1]Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med,1973,137(5)∶1142-1162.
  • 3[2]Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med,1992,176(6)∶1693-1702.
  • 4[3]Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med,1994,179(4)∶1109-1118.
  • 5[4]Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood,1997,90(9)∶3245-3287.
  • 6[5]Bancherean J and Steinma RM. Dendritic cells and the control of immunity. Nature,1998,392(6673)∶245-252.
  • 7[6]Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function ofdendritic cells. Curr Opin Immunol,1997,9(1)∶10-16.
  • 8[7]Strobl H, Bello-Fernandez C, Riedl E, et al. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood,1997,90(4)∶1425-1434.
  • 9[8]Thurnher M, Papesh C, Ramoner R, et al. In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy. Exp Hematol,1997,25(3)∶232-237.
  • 10[9]Fields RC, Osterholzer JJ, Fuller JA, et al. Comparative analysis of murine dendritic cells derived from spleen and bone marrow. J Immunother,1998,21(5)∶323-339.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部